# FDA Inspection 1122416 - Servi-Dent Inc. - March 13, 2020

Source: https://www.keypedia.com/records/fda_inspections/servi-dent-inc/bb83dc3d-6cc2-4f02-b770-4aea100b18f2
Source feed: FDA_Inspections

> FDA Inspection 1122416 for Servi-Dent Inc. on March 13, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122416
- Company Name: Servi-Dent Inc.
- Inspection Date: 2020-03-13
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1243371 - 2024-07-05](https://www.keypedia.com/records/fda_inspections/servi-dent-inc/efa419f5-78bc-4d3d-940c-7f132f1ca903)
- [FDA Inspection 1122416 - 2020-03-13](https://www.keypedia.com/records/fda_inspections/servi-dent-inc/929c823f-082f-49b7-be7a-092e39d3026b)
- [FDA Inspection 1094404 - 2019-06-27](https://www.keypedia.com/records/fda_inspections/servi-dent-inc/942cc949-bd1c-4b46-957c-dc759a0d53d5)

Company: https://www.keypedia.com/companies/servi-dent-inc/e21e9dd5-9c51-4384-9e6a-e8bab51c8a0b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d